A total of 281 T2DM patients and 111 healthy volunteers were enrolled to identify the IGF2BP2 gene rs1470579 and rs4402960 polymorphisms ; 86 patients were randomly selected and given a 12-week pioglitazone treatment ( 30 mg/day ) .